

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline metabolic process (GO:0006560) | 8.39246777 |
| 2 | transcription from mitochondrial promoter (GO:0006390) | 8.25173508 |
| 3 | embryonic process involved in female pregnancy (GO:0060136) | 7.21003227 |
| 4 | replication fork processing (GO:0031297) | 6.64365921 |
| 5 | DNA deamination (GO:0045006) | 6.48898072 |
| 6 | positive regulation of protein homooligomerization (GO:0032464) | 6.28614412 |
| 7 | establishment of apical/basal cell polarity (GO:0035089) | 6.07527647 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.91889849 |
| 9 | regulation of integrin activation (GO:0033623) | 5.85491794 |
| 10 | oxidative demethylation (GO:0070989) | 5.80208789 |
| 11 | regulation of protein homooligomerization (GO:0032462) | 5.59431510 |
| 12 | mitochondrial DNA metabolic process (GO:0032042) | 5.53567010 |
| 13 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 5.51258760 |
| 14 | establishment of monopolar cell polarity (GO:0061162) | 5.19639720 |
| 15 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 5.19639720 |
| 16 | mitotic G1 DNA damage checkpoint (GO:0031571) | 5.13013333 |
| 17 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.11530997 |
| 18 | ATP synthesis coupled proton transport (GO:0015986) | 5.11530997 |
| 19 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.09053853 |
| 20 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.09053853 |
| 21 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 5.01397342 |
| 22 | regulation of translational fidelity (GO:0006450) | 4.91220595 |
| 23 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.82880307 |
| 24 | DNA strand renaturation (GO:0000733) | 4.59435836 |
| 25 | * establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.57573446 |
| 26 | embryonic placenta development (GO:0001892) | 4.53551474 |
| 27 | ribosomal small subunit assembly (GO:0000028) | 4.52086208 |
| 28 | mitotic G1/S transition checkpoint (GO:0044819) | 4.51585001 |
| 29 | chaperone-mediated protein transport (GO:0072321) | 4.45867254 |
| 30 | formation of translation preinitiation complex (GO:0001731) | 4.44392730 |
| 31 | G1 DNA damage checkpoint (GO:0044783) | 4.40353302 |
| 32 | viral mRNA export from host cell nucleus (GO:0046784) | 4.35848394 |
| 33 | ribosomal small subunit biogenesis (GO:0042274) | 4.32549180 |
| 34 | mRNA cleavage (GO:0006379) | 4.25228119 |
| 35 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.22834822 |
| 36 | poly(A)+ mRNA export from nucleus (GO:0016973) | 4.22166694 |
| 37 | cellular response to zinc ion (GO:0071294) | 4.19644259 |
| 38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.19547611 |
| 39 | proteasome assembly (GO:0043248) | 4.15726912 |
| 40 | respiratory electron transport chain (GO:0022904) | 4.13324488 |
| 41 | viral transcription (GO:0019083) | 4.11755977 |
| 42 | negative regulation of cell cycle arrest (GO:0071157) | 4.11568804 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.10192582 |
| 44 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 4.08784057 |
| 45 | electron transport chain (GO:0022900) | 4.02702949 |
| 46 | translational termination (GO:0006415) | 4.01807561 |
| 47 | mitochondrial RNA metabolic process (GO:0000959) | 3.99910597 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 3.97041315 |
| 49 | base-excision repair (GO:0006284) | 3.93691804 |
| 50 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.89899442 |
| 51 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.89836783 |
| 52 | rRNA modification (GO:0000154) | 3.89667144 |
| 53 | ribosomal large subunit biogenesis (GO:0042273) | 3.88701488 |
| 54 | positive regulation of protein oligomerization (GO:0032461) | 3.87075321 |
| 55 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.86115423 |
| 56 | maturation of SSU-rRNA (GO:0030490) | 3.81395787 |
| 57 | cotranslational protein targeting to membrane (GO:0006613) | 3.80038826 |
| 58 | cellular response to ATP (GO:0071318) | 3.79204239 |
| 59 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.76020174 |
| 60 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.76020174 |
| 61 | NADH dehydrogenase complex assembly (GO:0010257) | 3.76020174 |
| 62 | protein targeting to ER (GO:0045047) | 3.75320743 |
| 63 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.74225662 |
| 64 | negative regulation of protein oligomerization (GO:0032460) | 3.72591561 |
| 65 | apoptotic process involved in morphogenesis (GO:0060561) | 3.69541578 |
| 66 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.68567155 |
| 67 | translational elongation (GO:0006414) | 3.67678494 |
| 68 | protein complex biogenesis (GO:0070271) | 3.66808262 |
| 69 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.60188190 |
| 70 | regulation of protein oligomerization (GO:0032459) | 3.59136054 |
| 71 | positive regulation of developmental pigmentation (GO:0048087) | 3.58813052 |
| 72 | protein localization to endoplasmic reticulum (GO:0070972) | 3.58296983 |
| 73 | tricarboxylic acid cycle (GO:0006099) | 3.57659825 |
| 74 | translation (GO:0006412) | 3.54036892 |
| 75 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.52318830 |
| 76 | non-recombinational repair (GO:0000726) | 3.52318830 |
| 77 | dosage compensation (GO:0007549) | 3.50120174 |
| 78 | IMP metabolic process (GO:0046040) | 3.49694639 |
| 79 | translational initiation (GO:0006413) | 3.49475283 |
| 80 | DNA damage response, detection of DNA damage (GO:0042769) | 3.48801380 |
| 81 | inner mitochondrial membrane organization (GO:0007007) | 3.48768581 |
| 82 | negative regulation of Ras GTPase activity (GO:0034261) | 3.48655736 |
| 83 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.48554658 |
| 84 | DNA integration (GO:0015074) | 3.47648555 |
| 85 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.46899174 |
| 86 | cullin deneddylation (GO:0010388) | 3.46240968 |
| 87 | peptidyl-histidine modification (GO:0018202) | 3.44607134 |
| 88 | negative regulation of mRNA processing (GO:0050686) | 3.43131993 |
| 89 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.42069427 |
| 90 | negative regulation of ligase activity (GO:0051352) | 3.40666579 |
| 91 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.40666579 |
| 92 | establishment of integrated proviral latency (GO:0075713) | 3.39195673 |
| 93 | positive regulation by host of viral transcription (GO:0043923) | 3.38595347 |
| 94 | IMP biosynthetic process (GO:0006188) | 3.38401413 |
| 95 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.38145564 |
| 96 | cellular component biogenesis (GO:0044085) | 3.37416968 |
| 97 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.31124673 |
| 98 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.31007120 |
| 99 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.31007120 |
| 100 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.31007120 |
| 101 | embryonic camera-type eye development (GO:0031076) | 3.29292800 |
| 102 | protein deneddylation (GO:0000338) | 3.29243712 |
| 103 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.29098360 |
| 104 | aerobic respiration (GO:0009060) | 3.29056314 |
| 105 | termination of RNA polymerase III transcription (GO:0006386) | 3.28466905 |
| 106 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.28466905 |
| 107 | base-excision repair, AP site formation (GO:0006285) | 3.27742305 |
| 108 | actin-myosin filament sliding (GO:0033275) | 3.26981522 |
| 109 | muscle filament sliding (GO:0030049) | 3.26981522 |
| 110 | trophectodermal cell differentiation (GO:0001829) | 3.26843777 |
| 111 | convergent extension (GO:0060026) | 3.26242121 |
| 112 | regulation of gene silencing by RNA (GO:0060966) | 3.26062317 |
| 113 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.26062317 |
| 114 | regulation of gene silencing by miRNA (GO:0060964) | 3.26062317 |
| 115 | purine nucleobase biosynthetic process (GO:0009113) | 3.25611893 |
| 116 | histone H4-K12 acetylation (GO:0043983) | 3.22491139 |
| 117 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.22475010 |
| 118 | regulation of sister chromatid cohesion (GO:0007063) | 3.21983422 |
| 119 | viral life cycle (GO:0019058) | 3.21982646 |
| 120 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.21644675 |
| 121 | ATP biosynthetic process (GO:0006754) | 3.21005312 |
| 122 | alkaloid metabolic process (GO:0009820) | 3.20418954 |
| 123 | * protein targeting to mitochondrion (GO:0006626) | 3.20335692 |
| 124 | pseudouridine synthesis (GO:0001522) | 3.18906192 |
| 125 | labyrinthine layer development (GO:0060711) | 3.18699658 |
| 126 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.18134622 |
| 127 | DNA topological change (GO:0006265) | 3.17800285 |
| 128 | GDP-mannose metabolic process (GO:0019673) | 3.16824316 |
| 129 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.16692884 |
| 130 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.16418924 |
| 131 | regulation of mitochondrial translation (GO:0070129) | 3.16402767 |
| 132 | protein neddylation (GO:0045116) | 3.15977234 |
| 133 | nucleobase biosynthetic process (GO:0046112) | 3.15589940 |
| 134 | anatomical structure regression (GO:0060033) | 3.15286144 |
| 135 | termination of RNA polymerase II transcription (GO:0006369) | 3.14697226 |
| 136 | chromatin remodeling at centromere (GO:0031055) | 3.13977673 |
| 137 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.12468997 |
| 138 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.12468997 |
| 139 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.12468997 |
| 140 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.12238106 |
| 141 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.12238106 |
| 142 | nodal signaling pathway (GO:0038092) | 3.11833876 |
| 143 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.11720819 |
| 144 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.11720819 |
| 145 | rRNA methylation (GO:0031167) | 3.10677941 |
| 146 | regulation of RNA export from nucleus (GO:0046831) | 3.09937174 |
| 147 | mitochondrial fusion (GO:0008053) | 3.07895477 |
| 148 | oxidative phosphorylation (GO:0006119) | 3.07731282 |
| 149 | CENP-A containing nucleosome assembly (GO:0034080) | 3.06890210 |
| 150 | cellular protein complex disassembly (GO:0043624) | 3.06802161 |
| 151 | spliceosomal snRNP assembly (GO:0000387) | 3.05759705 |
| 152 | tRNA aminoacylation for protein translation (GO:0006418) | 3.05693404 |
| 153 | glial cell migration (GO:0008347) | 3.05603984 |
| 154 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.05277131 |
| 155 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.05277131 |
| 156 | ubiquinone biosynthetic process (GO:0006744) | 3.04026178 |
| 157 | telomere maintenance via recombination (GO:0000722) | 3.02713079 |
| 158 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.02490422 |
| 159 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.01806836 |
| 160 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.01508122 |
| 161 | mitochondrial DNA replication (GO:0006264) | 3.00922549 |
| 162 | rRNA processing (GO:0006364) | 3.00679355 |
| 163 | * protein localization to mitochondrion (GO:0070585) | 3.00177044 |
| 164 | amino acid activation (GO:0043038) | 3.00051414 |
| 165 | tRNA aminoacylation (GO:0043039) | 3.00051414 |
| 166 | NADH metabolic process (GO:0006734) | 2.99965254 |
| 167 | maturation of 5.8S rRNA (GO:0000460) | 2.98029364 |
| 168 | negative regulation of RNA splicing (GO:0033119) | 2.97321197 |
| 169 | * establishment of protein localization to mitochondrion (GO:0072655) | 2.96912000 |
| 170 | DNA double-strand break processing (GO:0000729) | 2.96772764 |
| 171 | face development (GO:0060324) | 2.95455233 |
| 172 | regulation of cell size (GO:0008361) | 2.95182884 |
| 173 | DNA strand elongation (GO:0022616) | 2.95043684 |
| 174 | ribosome biogenesis (GO:0042254) | 2.94662163 |
| 175 | meiotic chromosome segregation (GO:0045132) | 2.94598519 |
| 176 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.93988599 |
| 177 | L-serine metabolic process (GO:0006563) | 2.93580768 |
| 178 | positive regulation of DNA repair (GO:0045739) | 2.93246338 |
| 179 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.93182430 |
| 180 | ubiquinone metabolic process (GO:0006743) | 2.92525768 |
| 181 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.91794673 |
| 182 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.90265472 |
| 183 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.89160209 |
| 184 | determination of adult lifespan (GO:0008340) | 2.82718045 |
| 185 | DNA demethylation (GO:0080111) | 2.80086099 |
| 186 | nuclear envelope reassembly (GO:0031468) | 2.79977668 |
| 187 | mitotic nuclear envelope reassembly (GO:0007084) | 2.79977668 |
| 188 | hypotonic response (GO:0006971) | 2.79319438 |
| 189 | regulation of DNA damage checkpoint (GO:2000001) | 2.79054449 |
| 190 | negative regulation of heart rate (GO:0010459) | 2.77153082 |
| 191 | DNA ligation (GO:0006266) | 2.76741649 |
| 192 | regulation of double-strand break repair (GO:2000779) | 2.75822325 |
| 193 | proline biosynthetic process (GO:0006561) | 10.9000306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.89593921 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.60242073 |
| 3 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.20727180 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.91268738 |
| 5 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.58447135 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.51010336 |
| 7 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 3.07150574 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.89581197 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.88632571 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.86251773 |
| 11 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.83985547 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.83201037 |
| 13 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.75238985 |
| 14 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.67647385 |
| 15 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.65361224 |
| 16 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.65361224 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.65361224 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.48446037 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42453677 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.42329254 |
| 21 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.29015301 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.28808788 |
| 23 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.27897024 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.27027230 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.22135835 |
| 26 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.19451568 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18621505 |
| 28 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.17783801 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.14231362 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.13127334 |
| 31 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.10740775 |
| 32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.07555115 |
| 33 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.05056057 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.03030816 |
| 35 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.02769107 |
| 36 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.00291157 |
| 37 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.99547138 |
| 38 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.97821299 |
| 39 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.91439331 |
| 40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88689922 |
| 41 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.87980361 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.87067562 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81060556 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.80558982 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.78463227 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.75947798 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75350187 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.74654322 |
| 49 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.73038812 |
| 50 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.68470190 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67475996 |
| 52 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.62699536 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.61477433 |
| 54 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.59456401 |
| 55 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58194901 |
| 56 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58184523 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.58141414 |
| 58 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.57692887 |
| 59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.55767062 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55640754 |
| 61 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.54601184 |
| 62 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.54243504 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54231388 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53457537 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.51034914 |
| 66 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.50807239 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50251773 |
| 68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.48339966 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48190717 |
| 70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.47761544 |
| 71 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45675521 |
| 72 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44393885 |
| 73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40800600 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39336078 |
| 75 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.39139290 |
| 76 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37327314 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.36672845 |
| 78 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35751545 |
| 79 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34961392 |
| 80 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33940724 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33266848 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32296567 |
| 83 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.31784017 |
| 84 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29384584 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29178361 |
| 86 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.28496134 |
| 87 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.26949920 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26485964 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25995510 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25288159 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24670527 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23780466 |
| 93 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.23723102 |
| 94 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23154820 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22814870 |
| 96 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22750918 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22667906 |
| 98 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.22165865 |
| 99 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.20942968 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20759052 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20302346 |
| 102 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.19874907 |
| 103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19779783 |
| 104 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.19629650 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19560353 |
| 106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19401122 |
| 107 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18925581 |
| 108 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18820046 |
| 109 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.17498529 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.16874631 |
| 111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15944496 |
| 112 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15421795 |
| 113 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.15411999 |
| 114 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14589701 |
| 115 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14298107 |
| 116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13819593 |
| 117 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.13805442 |
| 118 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13716973 |
| 119 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.13703494 |
| 120 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13513916 |
| 121 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12809373 |
| 122 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.11769708 |
| 123 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.11644713 |
| 124 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11196574 |
| 125 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10782810 |
| 126 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08974340 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08600725 |
| 128 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08593374 |
| 129 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07568484 |
| 130 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.07365753 |
| 131 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.06392972 |
| 132 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06097703 |
| 133 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.05430730 |
| 134 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.05197784 |
| 135 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05159519 |
| 136 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05146390 |
| 137 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05120545 |
| 138 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02914439 |
| 139 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02895389 |
| 140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02698770 |
| 141 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.02391233 |
| 142 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02210052 |
| 143 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.02069249 |
| 144 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01819778 |
| 145 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.01655646 |
| 146 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.99649192 |
| 147 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.95563354 |
| 148 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91731719 |
| 149 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91164007 |
| 150 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89870059 |
| 151 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.87880111 |
| 152 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.87013048 |
| 153 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86416957 |
| 154 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.85025206 |
| 155 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.82399317 |
| 156 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79931080 |
| 157 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.77951992 |
| 158 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75735626 |
| 159 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.74866530 |
| 160 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74740044 |
| 161 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.74721892 |
| 162 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.73443650 |
| 163 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67736182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.54669423 |
| 2 | MP0009278_abnormal_bone_marrow | 4.15848612 |
| 3 | MP0004233_abnormal_muscle_weight | 3.63080937 |
| 4 | MP0000372_irregular_coat_pigmentation | 3.56784141 |
| 5 | MP0005171_absent_coat_pigmentation | 3.56461193 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.47949638 |
| 7 | MP0010030_abnormal_orbit_morphology | 3.38681126 |
| 8 | MP0003646_muscle_fatigue | 3.28468543 |
| 9 | MP0000749_muscle_degeneration | 2.93725518 |
| 10 | MP0008789_abnormal_olfactory_epithelium | 2.63042603 |
| 11 | MP0002009_preneoplasia | 2.59125515 |
| 12 | MP0003186_abnormal_redox_activity | 2.49724540 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.32999321 |
| 14 | MP0004147_increased_porphyrin_level | 2.32001660 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.30730446 |
| 16 | MP0003283_abnormal_digestive_organ | 2.29555949 |
| 17 | MP0002938_white_spotting | 2.23866733 |
| 18 | MP0010094_abnormal_chromosome_stability | 2.19968439 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.17400051 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 2.10314373 |
| 21 | MP0001545_abnormal_hematopoietic_system | 2.10314373 |
| 22 | MP0002102_abnormal_ear_morphology | 2.08707437 |
| 23 | MP0008995_early_reproductive_senescence | 2.06771730 |
| 24 | MP0005365_abnormal_bile_salt | 2.05808989 |
| 25 | MP0004133_heterotaxia | 2.02306640 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 2.01799050 |
| 27 | MP0002269_muscular_atrophy | 1.96448536 |
| 28 | MP0001529_abnormal_vocalization | 1.93644121 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 1.92199940 |
| 30 | MP0005394_taste/olfaction_phenotype | 1.89372216 |
| 31 | MP0005499_abnormal_olfactory_system | 1.89372216 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.88393617 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.87903543 |
| 34 | MP0006035_abnormal_mitochondrial_morpho | 1.86086793 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.82202490 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.79620046 |
| 37 | MP0003136_yellow_coat_color | 1.78079420 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.73405172 |
| 39 | MP0003119_abnormal_digestive_system | 1.73376996 |
| 40 | MP0008007_abnormal_cellular_replicative | 1.70139975 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.65343375 |
| 42 | MP0002086_abnormal_extraembryonic_tissu | 1.63931668 |
| 43 | MP0005330_cardiomyopathy | 1.63454442 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.62829132 |
| 45 | MP0003786_premature_aging | 1.62025819 |
| 46 | MP0003567_abnormal_fetal_cardiomyocyte | 1.58943957 |
| 47 | MP0002249_abnormal_larynx_morphology | 1.56242453 |
| 48 | MP0001697_abnormal_embryo_size | 1.52194529 |
| 49 | MP0005408_hypopigmentation | 1.49813363 |
| 50 | MP0009697_abnormal_copulation | 1.49466104 |
| 51 | MP0000759_abnormal_skeletal_muscle | 1.48375872 |
| 52 | MP0002084_abnormal_developmental_patter | 1.48068637 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.47552969 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.45909774 |
| 55 | MP0004197_abnormal_fetal_growth/weight/ | 1.45171826 |
| 56 | MP0003111_abnormal_nucleus_morphology | 1.43941366 |
| 57 | MP0000371_diluted_coat_color | 1.43688956 |
| 58 | MP0002282_abnormal_trachea_morphology | 1.43643955 |
| 59 | MP0000490_abnormal_crypts_of | 1.40568695 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.37985846 |
| 61 | MP0000579_abnormal_nail_morphology | 1.36554677 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.36215631 |
| 63 | MP0001293_anophthalmia | 1.36131305 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.34869860 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.33826498 |
| 66 | MP0005266_abnormal_metabolism | 1.33571707 |
| 67 | MP0002085_abnormal_embryonic_tissue | 1.32151585 |
| 68 | MP0001672_abnormal_embryogenesis/_devel | 1.26170695 |
| 69 | MP0005380_embryogenesis_phenotype | 1.26170695 |
| 70 | MP0008932_abnormal_embryonic_tissue | 1.26019398 |
| 71 | MP0002796_impaired_skin_barrier | 1.24965957 |
| 72 | MP0000751_myopathy | 1.24769790 |
| 73 | MP0008058_abnormal_DNA_repair | 1.23685414 |
| 74 | MP0003137_abnormal_impulse_conducting | 1.19485053 |
| 75 | MP0010630_abnormal_cardiac_muscle | 1.18699766 |
| 76 | MP0005670_abnormal_white_adipose | 1.18323877 |
| 77 | MP0001730_embryonic_growth_arrest | 1.17883375 |
| 78 | MP0004084_abnormal_cardiac_muscle | 1.17364947 |
| 79 | MP0003077_abnormal_cell_cycle | 1.15115906 |
| 80 | MP0001661_extended_life_span | 1.14758112 |
| 81 | MP0000358_abnormal_cell_content/ | 1.14614801 |
| 82 | MP0005369_muscle_phenotype | 1.13287447 |
| 83 | MP0003828_pulmonary_edema | 1.12829631 |
| 84 | MP0000470_abnormal_stomach_morphology | 1.12813490 |
| 85 | MP0003878_abnormal_ear_physiology | 1.11536673 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 1.11536673 |
| 87 | MP0003941_abnormal_skin_development | 1.11402462 |
| 88 | MP0002638_abnormal_pupillary_reflex | 1.10933954 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.09977927 |
| 90 | MP0000639_abnormal_adrenal_gland | 1.09549819 |
| 91 | MP0005620_abnormal_muscle_contractility | 1.06411267 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 1.06137794 |
| 93 | MP0005360_urolithiasis | 1.05916520 |
| 94 | MP0002332_abnormal_exercise_endurance | 1.05204726 |
| 95 | MP0003693_abnormal_embryo_hatching | 1.04610511 |
| 96 | MP0001984_abnormal_olfaction | 1.04373232 |
| 97 | MP0004130_abnormal_muscle_cell | 1.04105849 |
| 98 | MP0002080_prenatal_lethality | 1.04102208 |
| 99 | MP0000350_abnormal_cell_proliferation | 1.03776565 |
| 100 | MP0000750_abnormal_muscle_regeneration | 1.03599116 |
| 101 | MP0003984_embryonic_growth_retardation | 1.03073276 |
| 102 | MP0009115_abnormal_fat_cell | 1.02542119 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 1.01618861 |
| 104 | MP0002019_abnormal_tumor_incidence | 1.01219594 |
| 105 | MP0006036_abnormal_mitochondrial_physio | 0.98724150 |
| 106 | MP0002088_abnormal_embryonic_growth/wei | 0.98647337 |
| 107 | MP0002111_abnormal_tail_morphology | 0.98056029 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.97736087 |
| 109 | MP0002163_abnormal_gland_morphology | 0.97650914 |
| 110 | MP0009672_abnormal_birth_weight | 0.96423933 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.95636600 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.95587842 |
| 113 | MP0004087_abnormal_muscle_fiber | 0.94606653 |
| 114 | MP0000462_abnormal_digestive_system | 0.94259540 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90991398 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.90786035 |
| 117 | MP0003011_delayed_dark_adaptation | 0.88702721 |
| 118 | MP0003315_abnormal_perineum_morphology | 0.87645834 |
| 119 | MP0005501_abnormal_skin_physiology | 0.86240841 |
| 120 | MP0002970_abnormal_white_adipose | 0.85774351 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.85299546 |
| 122 | MP0001340_abnormal_eyelid_morphology | 0.85149438 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.83629569 |
| 124 | MP0002139_abnormal_hepatobiliary_system | 0.83272116 |
| 125 | MP0004019_abnormal_vitamin_homeostasis | 0.82915813 |
| 126 | MP0004142_abnormal_muscle_tone | 0.82837889 |
| 127 | MP0002233_abnormal_nose_morphology | 0.82292775 |
| 128 | MP0010307_abnormal_tumor_latency | 0.82158431 |
| 129 | MP0002060_abnormal_skin_morphology | 0.80774083 |
| 130 | MP0002822_catalepsy | 0.79933244 |
| 131 | MP0002075_abnormal_coat/hair_pigmentati | 0.79279606 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.79065983 |
| 133 | MP0002160_abnormal_reproductive_system | 0.78840869 |
| 134 | MP0002971_abnormal_brown_adipose | 0.77842778 |
| 135 | MP0002210_abnormal_sex_determination | 0.77068484 |
| 136 | MP0003718_maternal_effect | 0.76196575 |
| 137 | MP0002932_abnormal_joint_morphology | 0.76186410 |
| 138 | MP0002106_abnormal_muscle_physiology | 0.76128238 |
| 139 | MP0000762_abnormal_tongue_morphology | 0.75716492 |
| 140 | MP0001286_abnormal_eye_development | 0.75596326 |
| 141 | MP0005023_abnormal_wound_healing | 0.75204340 |
| 142 | MP0003937_abnormal_limbs/digits/tail_de | 0.74969223 |
| 143 | MP0003121_genomic_imprinting | 0.74684989 |
| 144 | MP0002095_abnormal_skin_pigmentation | 0.74478466 |
| 145 | MP0000049_abnormal_middle_ear | 0.74344896 |
| 146 | MP0009053_abnormal_anal_canal | 0.73785430 |
| 147 | MP0005332_abnormal_amino_acid | 0.73060967 |
| 148 | MP0002697_abnormal_eye_size | 0.72789615 |
| 149 | MP0001346_abnormal_lacrimal_gland | 0.72281754 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.72219394 |
| 151 | MP0000609_abnormal_liver_physiology | 0.71371460 |
| 152 | MP0000313_abnormal_cell_death | 0.70913814 |
| 153 | MP0002736_abnormal_nociception_after | 0.70528621 |
| 154 | MP0000685_abnormal_immune_system | 0.70419623 |
| 155 | MP0005319_abnormal_enzyme/_coenzyme | 0.70068006 |
| 156 | MP0000747_muscle_weakness | 0.69662126 |
| 157 | MP0001485_abnormal_pinna_reflex | 0.69271543 |
| 158 | MP0002127_abnormal_cardiovascular_syste | 0.68874121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 5.20180867 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 5.14092359 |
| 3 | Rib fusion (HP:0000902) | 5.08454024 |
| 4 | Pustule (HP:0200039) | 5.06461031 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.91688323 |
| 6 | Annular pancreas (HP:0001734) | 4.80232289 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.72069517 |
| 8 | Concave nail (HP:0001598) | 4.69602867 |
| 9 | Turricephaly (HP:0000262) | 4.61924725 |
| 10 | Alopecia of scalp (HP:0002293) | 4.57461312 |
| 11 | Rectovaginal fistula (HP:0000143) | 4.52462190 |
| 12 | Rectal fistula (HP:0100590) | 4.52462190 |
| 13 | Facial hemangioma (HP:0000329) | 4.51699307 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.49096808 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 4.46484816 |
| 16 | Acute encephalopathy (HP:0006846) | 4.36291539 |
| 17 | Poikiloderma (HP:0001029) | 4.33495757 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 4.25541663 |
| 19 | Increased IgM level (HP:0003496) | 4.25376203 |
| 20 | Vaginal fistula (HP:0004320) | 4.18445836 |
| 21 | Ulnar bowing (HP:0003031) | 4.17946362 |
| 22 | Intestinal fistula (HP:0100819) | 4.00413274 |
| 23 | Mitochondrial inheritance (HP:0001427) | 3.96985056 |
| 24 | Abnormal hemoglobin (HP:0011902) | 3.95095557 |
| 25 | Increased CSF lactate (HP:0002490) | 3.77353475 |
| 26 | Tongue fasciculations (HP:0001308) | 3.73911842 |
| 27 | Hepatocellular necrosis (HP:0001404) | 3.71572766 |
| 28 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.71539878 |
| 29 | Increased serum pyruvate (HP:0003542) | 3.69791071 |
| 30 | Muscle fibrillation (HP:0010546) | 3.63570495 |
| 31 | Progressive macrocephaly (HP:0004481) | 3.63494402 |
| 32 | Hepatic necrosis (HP:0002605) | 3.56762048 |
| 33 | Short humerus (HP:0005792) | 3.56294094 |
| 34 | Abnormality of glycolysis (HP:0004366) | 3.53982730 |
| 35 | Coronal craniosynostosis (HP:0004440) | 3.46123549 |
| 36 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.44045284 |
| 37 | Male infertility (HP:0003251) | 3.40459875 |
| 38 | Cerebral edema (HP:0002181) | 3.37880568 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 3.35589263 |
| 40 | Orthostatic hypotension (HP:0001278) | 3.35442201 |
| 41 | Rhabdomyolysis (HP:0003201) | 3.35173138 |
| 42 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.33961655 |
| 43 | Vertebral hypoplasia (HP:0008417) | 3.33961655 |
| 44 | Exercise intolerance (HP:0003546) | 3.26065775 |
| 45 | Large for gestational age (HP:0001520) | 3.22073107 |
| 46 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.21882767 |
| 47 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20473290 |
| 48 | Lactic acidosis (HP:0003128) | 3.10918400 |
| 49 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.06223649 |
| 50 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.06223649 |
| 51 | Short chin (HP:0000331) | 3.06028326 |
| 52 | Congenital hip dislocation (HP:0001374) | 3.05508534 |
| 53 | Mucopolysacchariduria (HP:0008155) | 3.05483390 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.05483390 |
| 55 | Type 1 muscle fiber predominance (HP:0003803) | 3.05462117 |
| 56 | Reticulocytopenia (HP:0001896) | 3.04060889 |
| 57 | Diaphragmatic weakness (HP:0009113) | 2.99376932 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.99341467 |
| 59 | Polycythemia (HP:0001901) | 2.98155950 |
| 60 | Increased serum lactate (HP:0002151) | 2.96123420 |
| 61 | Increased muscle lipid content (HP:0009058) | 2.94589359 |
| 62 | Asymmetric septal hypertrophy (HP:0001670) | 2.94332816 |
| 63 | Intestinal atresia (HP:0011100) | 2.94046915 |
| 64 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.91052941 |
| 65 | Premature skin wrinkling (HP:0100678) | 2.89193064 |
| 66 | Squamous cell carcinoma (HP:0002860) | 2.84511312 |
| 67 | Basal cell carcinoma (HP:0002671) | 2.84403852 |
| 68 | Myopathic facies (HP:0002058) | 2.84084727 |
| 69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.81892761 |
| 70 | Abnormality of alanine metabolism (HP:0010916) | 2.81892761 |
| 71 | Hyperalaninemia (HP:0003348) | 2.81892761 |
| 72 | Abnormality of male internal genitalia (HP:0000022) | 2.80440903 |
| 73 | Rimmed vacuoles (HP:0003805) | 2.76350967 |
| 74 | Absent radius (HP:0003974) | 2.74071921 |
| 75 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.73863921 |
| 76 | Anteriorly placed anus (HP:0001545) | 2.73609284 |
| 77 | Broad alveolar ridges (HP:0000187) | 2.72188773 |
| 78 | Albinism (HP:0001022) | 2.72048001 |
| 79 | Growth hormone excess (HP:0000845) | 2.70239499 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68915146 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68915146 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68915146 |
| 83 | Cerebral aneurysm (HP:0004944) | 2.67091845 |
| 84 | Renal Fanconi syndrome (HP:0001994) | 2.65170449 |
| 85 | Absent thumb (HP:0009777) | 2.63981278 |
| 86 | Exercise-induced myalgia (HP:0003738) | 2.62913064 |
| 87 | Dysostosis multiplex (HP:0000943) | 2.61873436 |
| 88 | Selective tooth agenesis (HP:0001592) | 2.61856301 |
| 89 | Abnormal number of erythroid precursors (HP:0012131) | 2.61620151 |
| 90 | Dysautonomia (HP:0002459) | 2.60443679 |
| 91 | Hypochromic anemia (HP:0001931) | 2.58418626 |
| 92 | Hypotrichosis (HP:0001006) | 2.57392267 |
| 93 | Distal arthrogryposis (HP:0005684) | 2.55947184 |
| 94 | Hamartoma (HP:0010566) | 2.55643313 |
| 95 | Abnormality of the aortic arch (HP:0012303) | 2.55039150 |
| 96 | Type I transferrin isoform profile (HP:0003642) | 2.54786462 |
| 97 | Alacrima (HP:0000522) | 2.54727326 |
| 98 | Absent forearm bone (HP:0003953) | 2.53800797 |
| 99 | Aplasia involving forearm bones (HP:0009822) | 2.53800797 |
| 100 | Muscle fiber atrophy (HP:0100295) | 2.51852276 |
| 101 | Joint stiffness (HP:0001387) | 2.48904905 |
| 102 | Respiratory failure (HP:0002878) | 2.48789126 |
| 103 | Macrocytic anemia (HP:0001972) | 2.47775756 |
| 104 | Ketoacidosis (HP:0001993) | 2.47506339 |
| 105 | Calf muscle hypertrophy (HP:0008981) | 2.44660708 |
| 106 | Hypokinesia (HP:0002375) | 2.39512677 |
| 107 | Bowed forearm bones (HP:0003956) | 2.37347368 |
| 108 | Bowing of the arm (HP:0006488) | 2.37347368 |
| 109 | Microvesicular hepatic steatosis (HP:0001414) | 2.35855791 |
| 110 | Generalized amyotrophy (HP:0003700) | 2.32364570 |
| 111 | Choanal stenosis (HP:0000452) | 2.30989410 |
| 112 | Respiratory difficulties (HP:0002880) | 2.30914633 |
| 113 | Myoglobinuria (HP:0002913) | 2.29895087 |
| 114 | 3-Methylglutaconic aciduria (HP:0003535) | 2.27157576 |
| 115 | Hyperglycinuria (HP:0003108) | 2.21919165 |
| 116 | Leukodystrophy (HP:0002415) | 2.20008956 |
| 117 | Hypobetalipoproteinemia (HP:0003563) | 2.19740385 |
| 118 | Astrocytoma (HP:0009592) | 2.19538939 |
| 119 | Abnormality of the astrocytes (HP:0100707) | 2.19538939 |
| 120 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.18445133 |
| 121 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.18445133 |
| 122 | Bulbar palsy (HP:0001283) | 2.16704226 |
| 123 | Optic disc pallor (HP:0000543) | 2.16676149 |
| 124 | Redundant skin (HP:0001582) | 2.16448437 |
| 125 | Myotonia (HP:0002486) | 2.13776941 |
| 126 | Calcaneovalgus deformity (HP:0001848) | 2.13642786 |
| 127 | IgA deficiency (HP:0002720) | 2.13367643 |
| 128 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.13011173 |
| 129 | Vertebral fusion (HP:0002948) | 2.11713592 |
| 130 | Lower limb hyperreflexia (HP:0002395) | 2.11158906 |
| 131 | Premature graying of hair (HP:0002216) | 2.10746387 |
| 132 | Hypercortisolism (HP:0001578) | 2.10578284 |
| 133 | Patellar aplasia (HP:0006443) | 2.10522272 |
| 134 | Bifid uvula (HP:0000193) | 2.09704270 |
| 135 | Hypotelorism (HP:0000601) | 2.08972946 |
| 136 | Volvulus (HP:0002580) | 2.07814890 |
| 137 | Hyperglycinemia (HP:0002154) | 2.07086458 |
| 138 | Clumsiness (HP:0002312) | 2.07037122 |
| 139 | Progressive muscle weakness (HP:0003323) | 2.06012507 |
| 140 | Stenosis of the external auditory canal (HP:0000402) | 2.04184969 |
| 141 | Abnormal protein glycosylation (HP:0012346) | 2.04143037 |
| 142 | Abnormal glycosylation (HP:0012345) | 2.04143037 |
| 143 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.04143037 |
| 144 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.04143037 |
| 145 | Aplasia of the musculature (HP:0100854) | 2.03400146 |
| 146 | Amniotic constriction ring (HP:0009775) | 2.01935947 |
| 147 | Abnormality of placental membranes (HP:0011409) | 2.01935947 |
| 148 | Multiple enchondromatosis (HP:0005701) | 2.01693579 |
| 149 | Lethargy (HP:0001254) | 2.01587476 |
| 150 | Abnormality of glycine metabolism (HP:0010895) | 1.99101832 |
| 151 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99101832 |
| 152 | Cerebral hypomyelination (HP:0006808) | 1.98337672 |
| 153 | EMG: myopathic abnormalities (HP:0003458) | 1.97912224 |
| 154 | Abnormality of serum amino acid levels (HP:0003112) | 1.97370480 |
| 155 | Abnormality of the lower motor neuron (HP:0002366) | 1.96148317 |
| 156 | Capillary hemangiomas (HP:0005306) | 1.93839372 |
| 157 | Dicarboxylic aciduria (HP:0003215) | 1.92396231 |
| 158 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92396231 |
| 159 | Hyperammonemia (HP:0001987) | 1.91191586 |
| 160 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.89795676 |
| 161 | Deformed tarsal bones (HP:0008119) | 1.88623895 |
| 162 | Ketosis (HP:0001946) | 1.87878777 |
| 163 | Degeneration of anterior horn cells (HP:0002398) | 1.87141377 |
| 164 | Abnormality of the anterior horn cell (HP:0006802) | 1.87141377 |
| 165 | CNS demyelination (HP:0007305) | 1.86056108 |
| 166 | Ragged-red muscle fibers (HP:0003200) | 1.85142484 |
| 167 | Abnormality of the calf musculature (HP:0001430) | 1.84467787 |
| 168 | Neck muscle weakness (HP:0000467) | 1.84110212 |
| 169 | Gastrointestinal dysmotility (HP:0002579) | 1.83800960 |
| 170 | Reduced antithrombin III activity (HP:0001976) | 1.83716563 |
| 171 | Popliteal pterygium (HP:0009756) | 1.82608363 |
| 172 | Neoplasm of the adrenal gland (HP:0100631) | 1.82056435 |
| 173 | Muscle stiffness (HP:0003552) | 1.81682925 |
| 174 | Split hand (HP:0001171) | 1.81665252 |
| 175 | Colon cancer (HP:0003003) | 1.81278634 |
| 176 | Pancreatic fibrosis (HP:0100732) | 1.77696592 |
| 177 | Gastrointestinal atresia (HP:0002589) | 1.77217563 |
| 178 | Abnormality of the labia minora (HP:0012880) | 1.77064976 |
| 179 | Methylmalonic acidemia (HP:0002912) | 1.76495483 |
| 180 | Metaphyseal cupping (HP:0003021) | 1.76367056 |
| 181 | Decreased lacrimation (HP:0000633) | 1.74895742 |
| 182 | Ependymoma (HP:0002888) | 1.74694923 |
| 183 | Shoulder girdle muscle weakness (HP:0003547) | 1.71988593 |
| 184 | Aplastic anemia (HP:0001915) | 1.70709150 |
| 185 | Horseshoe kidney (HP:0000085) | 1.70465623 |
| 186 | Pancytopenia (HP:0001876) | 1.70186955 |
| 187 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.68809510 |
| 188 | Methylmalonic aciduria (HP:0012120) | 1.68690467 |
| 189 | Type 2 muscle fiber atrophy (HP:0003554) | 1.68393125 |
| 190 | Microretrognathia (HP:0000308) | 1.67919156 |
| 191 | Abnormality of renal resorption (HP:0011038) | 1.63881230 |
| 192 | Pallor (HP:0000980) | 1.60026291 |
| 193 | X-linked dominant inheritance (HP:0001423) | 1.58802553 |
| 194 | Paralysis (HP:0003470) | 1.58384423 |
| 195 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.57174438 |
| 196 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.56954700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 5.80708200 |
| 2 | MAPK15 | 4.91281028 |
| 3 | DDR2 | 4.76153492 |
| 4 | MAP3K6 | 4.27022792 |
| 5 | VRK2 | 4.20046420 |
| 6 | OBSCN | 3.93213430 |
| 7 | TSSK6 | 3.65636357 |
| 8 | MAP3K11 | 3.53586089 |
| 9 | PINK1 | 3.25197757 |
| 10 | MATK | 2.80144689 |
| 11 | TYRO3 | 2.75268769 |
| 12 | SRPK1 | 2.61249309 |
| 13 | FGR | 2.60992152 |
| 14 | DAPK1 | 2.35659866 |
| 15 | STK16 | 2.32253031 |
| 16 | PDK2 | 2.28086899 |
| 17 | BMX | 2.25133634 |
| 18 | PBK | 2.18931649 |
| 19 | UHMK1 | 2.16914861 |
| 20 | PIM2 | 2.15127211 |
| 21 | PDGFRA | 2.13063824 |
| 22 | EIF2AK1 | 2.07594966 |
| 23 | CSK | 2.05811829 |
| 24 | VRK1 | 2.03695735 |
| 25 | DYRK1B | 1.99441941 |
| 26 | PRKD2 | 1.97956352 |
| 27 | NUAK1 | 1.91088786 |
| 28 | TRIM28 | 1.86262987 |
| 29 | ZAK | 1.85435163 |
| 30 | NME1 | 1.81729051 |
| 31 | YES1 | 1.73375944 |
| 32 | CDK7 | 1.68506215 |
| 33 | LIMK1 | 1.58254059 |
| 34 | EIF2AK3 | 1.53667369 |
| 35 | PLK3 | 1.53468511 |
| 36 | TAF1 | 1.50209781 |
| 37 | MAP3K10 | 1.48421731 |
| 38 | PLK4 | 1.47824996 |
| 39 | PHKG1 | 1.45754911 |
| 40 | PHKG2 | 1.45754911 |
| 41 | TRIB3 | 1.45273771 |
| 42 | CDK6 | 1.44962302 |
| 43 | LATS2 | 1.42285834 |
| 44 | DYRK2 | 1.40219100 |
| 45 | PIM1 | 1.34714002 |
| 46 | TRPM7 | 1.34308088 |
| 47 | TIE1 | 1.29735418 |
| 48 | MAPK11 | 1.29722675 |
| 49 | BMPR1B | 1.28691337 |
| 50 | RPS6KL1 | 1.24653677 |
| 51 | RPS6KC1 | 1.24653677 |
| 52 | BCKDK | 1.19061384 |
| 53 | NEK1 | 1.15939024 |
| 54 | CDC42BPA | 1.13742654 |
| 55 | MKNK1 | 1.11672865 |
| 56 | CSNK1G3 | 1.08938138 |
| 57 | RPS6KA6 | 1.07441626 |
| 58 | GSK3A | 1.04000218 |
| 59 | ARAF | 1.03289398 |
| 60 | AKT3 | 0.98545142 |
| 61 | CSNK1G1 | 0.93854730 |
| 62 | WNK3 | 0.91384960 |
| 63 | MST4 | 0.90031395 |
| 64 | EIF2AK2 | 0.89986966 |
| 65 | RPS6KB2 | 0.88628585 |
| 66 | TLK1 | 0.87116645 |
| 67 | MAP3K12 | 0.87080613 |
| 68 | BRAF | 0.86562661 |
| 69 | DYRK3 | 0.86134633 |
| 70 | CHEK2 | 0.85258310 |
| 71 | CDK19 | 0.84850415 |
| 72 | PLK1 | 0.80773254 |
| 73 | MTOR | 0.79907177 |
| 74 | CSNK1A1L | 0.79012725 |
| 75 | CSNK1G2 | 0.77042432 |
| 76 | CDK8 | 0.76238549 |
| 77 | DAPK3 | 0.75048486 |
| 78 | MKNK2 | 0.74863553 |
| 79 | PRKAA1 | 0.73275798 |
| 80 | SCYL2 | 0.73192234 |
| 81 | MAPKAPK3 | 0.72435553 |
| 82 | RPS6KA1 | 0.71431916 |
| 83 | BRSK1 | 0.70139887 |
| 84 | CCNB1 | 0.69427106 |
| 85 | SMG1 | 0.69414136 |
| 86 | TAOK2 | 0.68365679 |
| 87 | RPS6KA5 | 0.67791994 |
| 88 | FLT3 | 0.65243313 |
| 89 | PKN2 | 0.63505078 |
| 90 | HIPK2 | 0.62675885 |
| 91 | MAP4K2 | 0.59834979 |
| 92 | KDR | 0.56209368 |
| 93 | TTN | 0.55935195 |
| 94 | MAPKAPK5 | 0.55740090 |
| 95 | LRRK2 | 0.55405729 |
| 96 | RAF1 | 0.54680516 |
| 97 | TGFBR1 | 0.54613470 |
| 98 | NEK2 | 0.53505331 |
| 99 | CDK12 | 0.52647183 |
| 100 | TESK1 | 0.52032167 |
| 101 | ERBB4 | 0.51356566 |
| 102 | ILK | 0.51057575 |
| 103 | DMPK | 0.50878657 |
| 104 | EPHA2 | 0.50718426 |
| 105 | MUSK | 0.49274666 |
| 106 | GRK1 | 0.48901058 |
| 107 | PNCK | 0.48745026 |
| 108 | ATR | 0.48651856 |
| 109 | WNK4 | 0.48379690 |
| 110 | ABL2 | 0.47884834 |
| 111 | RPS6KA4 | 0.47194991 |
| 112 | ERBB3 | 0.47120824 |
| 113 | WEE1 | 0.46624263 |
| 114 | MOS | 0.46454518 |
| 115 | RIPK1 | 0.44603953 |
| 116 | CDK2 | 0.44288242 |
| 117 | BCR | 0.43512239 |
| 118 | CSNK1E | 0.41870229 |
| 119 | EGFR | 0.41562002 |
| 120 | AURKA | 0.40264661 |
| 121 | CDK4 | 0.40126850 |
| 122 | PRKAA2 | 0.39919501 |
| 123 | CSNK2A1 | 0.39886016 |
| 124 | STK4 | 0.39539702 |
| 125 | PAK1 | 0.39025326 |
| 126 | GRK5 | 0.37871236 |
| 127 | PDK4 | 0.37614008 |
| 128 | PDK3 | 0.37614008 |
| 129 | TAOK1 | 0.37122827 |
| 130 | ALK | 0.37100254 |
| 131 | CAMK2G | 0.36923218 |
| 132 | CDK3 | 0.36580219 |
| 133 | CDC7 | 0.36560443 |
| 134 | TESK2 | 0.35633874 |
| 135 | EPHB2 | 0.34672047 |
| 136 | MAPK4 | 0.33857658 |
| 137 | RPS6KB1 | 0.33550241 |
| 138 | BUB1 | 0.33441008 |
| 139 | SIK1 | 0.33439570 |
| 140 | PDGFRB | 0.31777357 |
| 141 | MAPK1 | 0.31478647 |
| 142 | MAPK3 | 0.31408217 |
| 143 | LYN | 0.31019335 |
| 144 | CSNK1A1 | 0.30952647 |
| 145 | ERN1 | 0.30866125 |
| 146 | AURKB | 0.30657057 |
| 147 | CSNK2A2 | 0.30144302 |
| 148 | STK39 | 0.29508171 |
| 149 | MAP3K9 | 0.29126082 |
| 150 | PAK4 | 0.28843909 |
| 151 | NME2 | 0.28242633 |
| 152 | PAK2 | 0.27909050 |
| 153 | STK10 | 0.27740160 |
| 154 | PTK2 | 0.26836667 |
| 155 | PRPF4B | 0.26155438 |
| 156 | PRKD1 | 0.25675823 |
| 157 | CHEK1 | 0.25089322 |
| 158 | MAP3K8 | 0.24399824 |
| 159 | EEF2K | 0.23552934 |
| 160 | MAPKAPK2 | 0.22431003 |
| 161 | MAPK14 | 0.21459477 |
| 162 | CAMK2B | 0.20913222 |
| 163 | CAMK2D | 0.20871649 |
| 164 | ATM | 0.20506728 |
| 165 | MAPK10 | 0.20447114 |
| 166 | AKT2 | 0.20238824 |
| 167 | TTK | 0.19309374 |
| 168 | STK3 | 0.18729271 |
| 169 | INSR | 0.18476132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.01472622 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.34944668 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.98756590 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.66199458 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.49584656 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.29809174 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.17137041 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.09544618 |
| 9 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.45440789 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.31404353 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.25432019 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.23241356 |
| 13 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.20212924 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.17726846 |
| 15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.00267449 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97394969 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.91540776 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.85875367 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.84087245 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83128882 |
| 21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.78042696 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.77908219 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.74955872 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.69834000 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68579771 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64076275 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.60656512 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.58071102 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.55310053 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.53989295 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.51863483 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.47600096 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46597141 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.41896076 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41860194 |
| 36 | Circadian rhythm_Homo sapiens_hsa04710 | 1.36772364 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.35717095 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.35518487 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32818141 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.32593112 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32288725 |
| 42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.27538791 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.27460053 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 1.26614599 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26502161 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25648125 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22630475 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.22011939 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20447438 |
| 50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.13923476 |
| 51 | Adherens junction_Homo sapiens_hsa04520 | 1.13650692 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12250479 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 1.10672538 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.09904568 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.09275812 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09221146 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 1.08371722 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07943421 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05944742 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04739081 |
| 61 | Ribosome_Homo sapiens_hsa03010 | 1.03408926 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97908903 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92710514 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92262895 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 0.89845627 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88013342 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84887410 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84801067 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84383523 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83632912 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82142044 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.81919447 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81234312 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77873676 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74589579 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74587870 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74582576 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73616791 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71351151 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70992168 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.67507051 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66918489 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.61747703 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60080071 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59820094 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59690704 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59452424 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59402364 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58490362 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57626063 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57238359 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56006756 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54356321 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52645541 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51564530 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51282971 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49486146 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48730571 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48174651 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46941424 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46211067 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43228328 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.42738992 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42606469 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42438687 |
| 106 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41727951 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40599290 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40387693 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38708721 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37898462 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36736158 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36675802 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.36465750 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35624702 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35599691 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35219548 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35186331 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35151825 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33516326 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32972525 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31520262 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30946367 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30438246 |
| 124 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29171421 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.28735340 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27751591 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27085426 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25373337 |
| 129 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.23850161 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23791621 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23460851 |
| 132 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23093368 |
| 133 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.16607447 |
| 134 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.15587582 |
| 135 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14923257 |
| 136 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.13516058 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12445386 |
| 138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12123455 |
| 139 | Phototransduction_Homo sapiens_hsa04744 | 0.10680622 |

